BOT 0.00% 38.0¢ botanix pharmaceuticals ltd

Ann: FDA Confirms Approach to Sofdra NDA Resubmission, page-44

  1. 70 Posts.
    lightbulb Created with Sketch. 25
    You do realise that you are just as annoying as him with your constant "approval by March" ramping. You need to give it a rest and stop with the misinformation. Consider what affect your posts can have on new investors that could potentially take what you say as fact.


 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.